MedPath

Early Prediction of QFR in STEMI-Pharmaco-invasice

Conditions
ST Segment Elevation Myocardial Infarction
Interventions
Diagnostic Test: Computation of quantitative flow ratio
Registration Number
NCT04220736
Lead Sponsor
RenJi Hospital
Brief Summary

The study intends to provide important data on whether the noval method using quantitative flow ratio could predict microvascular dysfunction.

Detailed Description

Microvascular dysfunction (MVD) is a serious complication of PCI, which happens frequently after STEMI and always correlates with a poor prognosis. However, precise and simplified assessment of MVD is difficult, especially in the acute phase of STEMI patients. Resent studies suggested that FFR could be overestimated when MVD exists. But whether the overestimated value of FFR caused by CMR defined MVO could reflect microcirculation function is still unclear.

This study is a retrospective study using STEMI patients who underwent pharmaco-invasive strategy as the population. Contrast-enhanced CMR was performed 5 days after PCI as the reference standard.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  • STEMI patients treated with revasculation within 12 hours from onset of symptoms to PCI time and received CMR 5 days afterwards. STEMI was defined as a combination of the following: chest pain for more than 30min, electrocardiographic (ECG) changing with ST segment elevation of >2 mm in at least 2 precordial leads and >1 mm in limb leads, and abnormal troponin levels or CKMB levels higher than twice the upper limit of normal.
  • Patients underwent successfully pharmaco-invasive strategy with half-dose alteplase.
Exclusion Criteria
  • Patients with left bundle branch block in the presenting ECG, cardiogenic shock, PCI or bypass surgery history.
  • Patients with residual stenosis <50%.
  • Patients with unqualified coronary angiographic images with problems such as ostial lesion, severe vessel tortuosity and diffuse long lesions.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
MVO groupComputation of quantitative flow ratioCMR was performed in all the cases. According to the results of CMR, we divided the study population into MVO group and Non-MVO group.
Non-MVO groupComputation of quantitative flow ratioCMR was performed in all the cases. According to the results of CMR, we divided the study population into MVO group and Non-MVO group.
Primary Outcome Measures
NameTimeMethod
Cardiac magnetic resonance (CMR)Five days after PCI

Cardiac magnetic resonance (CMR) is a non-invasive test for MVO assessing

Secondary Outcome Measures
NameTimeMethod
TIMI Flow Grade (TFG)One mins after PCI

TIMI Flow Grade (TFG) assesses flow in the epicardial arteries. Type zero perfusion expressed not antegrade movement away the occlusion; type two is a minimum, inadequate perfusion of contrast average round the mass; type three (partial perfusion) is a perfect just limited perfusion from the distal coronary bed by contrast element; and type three (complete perfusion) is an antegrade movement to the whole distal artery at a regular flow.

TIMI Myocardial Perfusion Grade (TMPG)One mins after PCI

TIMI Myocardial Perfusion Grade (TMPG) assesses flow in the micrevessels. TMPG0: no or minimal blush; TMPG1: Stain present Blush persists on next injection; TMPG2: Dye strongly persistent at end of washout Gone by next injection; TMPG3: normal ground glass appearance of blush Dye mildly persistentat end of washout.

Trial Locations

Locations (1)

Ren Ji Hospital Affliated to School of Medicine, Shanghai Jiao Tong University

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath